New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer

Dedifferentiated thyroid cancer (DeTC) derived from follicular epithelium is often incurable because it does not respond to radioiodine, radiotherapy, or chemotherapy. In cases, RET/PTC rearrangements are found in 30%–40%, RAS mutations in about 10%, and BRAF mutations in around 40%–50%, with no ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonelli, Alessandro, Ferri, Clodoveo, Ferrari, Silvia Martina, Sebastiani, Marco, Colaci, Michele, Ruffilli, Ilaria, Fallahi, Poupak
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902220/
https://www.ncbi.nlm.nih.gov/pubmed/20628483
http://dx.doi.org/10.1155/2010/921682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902220/
https://www.ncbi.nlm.nih.gov/pubmed/20628483
http://dx.doi.org/10.1155/2010/921682

Ejemplares similares